Talk:MDAT: Difference between revisions
Appearance
Content deleted Content added
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
{{chemicals|class=stub|importance=low}} |
{{chemicals|class=stub|importance=low}} |
||
⚫ | |||
I rewort the article because although there was a source, the info in the wiki page was completely contradictory to the results of the rat study. This is most likely because it is being sold as a research chemical, and vendors want to make it seem worthwhil to purchase. I will quote the lines that prove this: |
|||
6,7- and 5,6-(methylenedioxy)-2-aminotetralin (3b and 4b, respectively) were tested for stimulus generalization in the two-lever drug-discrimination paradigm |
|||
'''(5,6-(methylenedioxy)-2-aminotetralin is MDAT, called 4b in the study)''' |
|||
Now the results: Compounds 4a and '''4b did not substitute in MDMA-trained rats''' |
|||
HOWEVER |
|||
'''3b fully substituted in MDMA-trained rats''' |
|||
⚫ |
Revision as of 11:35, 2 June 2010
Pharmacology Unassessed | ||||||||||
|
Chemicals Stub‑class Low‑importance | ||||||||||
|
Never mind, completly misread the study and IUPAC name --Rollie (talk) 11:35, 2 June 2010 (UTC)